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The immune response in the intestine is a tightly 
controlled balance between innate and adaptive 
effector responses and negative regulatory path-
ways of control (Bouma and Strober, 2003; 
Izcue et al., 2009). Disruption of this balance 
by genetic or environmental factors can lead to 
chronic inflammatory syndromes such as the   
inflammatory bowel diseases (IBDs).
CD4+Foxp3+ T reg cells (Foxp3+ T reg 
cells) play a nonredundant role in immune ho-
meostasis, preventing pathological inflamma-
tory responses to environmental and self-antigens 
(Sakaguchi et al., 2008; Shevach, 2009). Loss of 
function mutations in the FOXP3 gene lead to 
impaired T reg cell function and the develop-
ment of a severe multiorgan inflammatory dis-
ease (Bennett et al., 2001). In humans, this is 
called immune dysregulation polyendocrinopa-
thy enteropathy, X-linked syndrome, and com-
monly involves severe intestinal inflammation, 
thus illustrating the importance of T reg cells in 
control of intestinal immune function.
Mouse  models  of  intestinal  inflammation 
have also pinpointed a key role for T reg cells 
in intestinal homeostasis, as illustrated in a 
model of T cell–driven colitis induced by the 
transfer of naive CD4 T cells into RAG/ 
mice (Izcue et al., 2009). Disease development 
can be prevented and cured by transfer of 
CD4+CD25+ T reg cells, providing a tractable 
model to unravel factors controlling the accu-
mulation and function of colitogenic and T reg 
cells in vivo (Coombes et al., 2005).
Understanding how particular co-stimulatory 
pathways affect both effector T (T eff) cell and 
T reg cell responses is crucial for development 
of  antiinflammatory  strategies  based  on  co-
stimulatory blockade, as interventions that in-
hibit both types of response may not reset the 
immunological balance in favor of T reg cells.
OX40  is  a  member  of  the  large  TNF/
TNFR family of co-stimulatory molecules that 
control lymphocyte function. OX40 is ex-
pressed primarily on activated T cells and its   
ligand OX40L on activated APC and LTi cells 
(Watts, 2005). The OX40–OX40L pathway 
plays an important role in the sustenance of 
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The immune response in the gastrointestinal tract is a tightly controlled balance between 
effector and regulatory cell responses. Here, we have investigated the role of OX40 in 
influencing the balance between conventional T cells and Foxp3+ regulatory T (T reg) cells. 
Under steady-state conditions, OX40 was required by T reg cells for their accumulation in 
the colon, but not peripheral lymphoid organs. Strikingly, under inflammatory conditions 
OX40 played an essential role in T reg cell–mediated suppression of colitis. OX40/  
T reg cells showed reduced accumulation in the colon and peripheral lymphoid organs, 
resulting in their inability to keep pace with the effector response. In the absence of OX40 
signaling, T reg cells underwent enhanced activation-induced cell death, indicating that 
OX40 delivers an important survival signal to T reg cells after activation. As OX40 also 
promoted the colitogenic Th1 response, its expression on T reg cells may be required for 
effective competition with OX40-dependent effector responses.
These results newly identify a key role for OX40 in the homeostasis of intestinal Foxp3+ 
T reg cells and in suppression of colitis. These findings should be taken into account when 
considering OX40 blockade for treatment of IBD.
© 2010 Griseri et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share  Alike–No  Mirror  Sites  license  for  the  first  six  months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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from WT compared with OX40/ cells in the spleen (mean 
ratio 1.7:1, WT/OX40/; Fig. 1 C). Consistent with results 
observed in OX40/ mice, there was a highly significant 
skew toward WT-derived cells among colonic Foxp3+ T reg 
cells (average ratio 6:1, WT/OX40/; Fig. 1 C). Together, 
these results show that OX40 acts directly on T reg cells to 
promote their accumulation in the intestine.
Although the differences were most marked for Foxp3+ 
cells, TCR+Foxp3 cells in the colon were also preferen-
tially derived from WT progeny (average ratio 2.5:1, WT/
OX40/; Fig. 1 C). This probably reflects a positive effect 
of OX40 on the homeostasis of CD4+Foxp3 T cells that 
express OX40 (29%; Fig. 1 A). In the colon, spleen, and 
MLN of unmanipulated mice, no differences were observed 
in the percentages of CD4+Foxp3 T cells presenting an   
activated/memory phenotype (CD44+CD62L) between 
OX40/ and WT mice (Fig. S1).
The frequency of Foxp3+ T reg cells was also 1.5- and 1.7-
fold reduced in the lung and liver, respectively, of OX40/ 
compared with WT mice (Fig. S1). These results suggest that 
OX40 promotes T reg cell accumulation in other tissues,   
although the effects are modest compared with the colon.
OX40 expression on T reg cells is required to suppress  
T cell–induced colitis
To determine if OX40 expression by T reg cells is necessary 
for their suppressive function in vivo, we tested their capac-
ity to prevent the development of T cell–induced colitis. 
RAG/ mice transferred with naive CD4+CD45RBhi T cells 
developed wasting disease and colitis (Fig. 2), whereas co-
transfer of WT CD4+CD25+ T reg cells with naive CD4+ 
T cells prevented development of disease. Strikingly, cotrans-
fer of OX40/ CD4+CD25+ T reg cells failed to prevent 
systemic or mucosal inflammation. Indeed, the incidence and 
severity of colitis in this group was indistinguishable from 
those that received colitogenic T cells alone (Fig. 2, A–D).
Our previous work has shown that T reg cells act on   
T cells and innate immune cells to inhibit colitis (Maloy et al., 
2003). OX40/ T reg cells on the other hand were ineffi-
cient in suppressing both arms of the colitogenic response. 
Marked  increases  in  CD4+IFN-+  T  cells  (8-fold)  and 
CD4+IL-17+ T cells (6-fold), as well as in inflammatory 
monocytes/macrophages (7-fold) and neutrophils (20-fold), 
were observed at wk 8 in the colon of mice restored with 
colitogenic T cells plus OX40/ T reg cells compared with 
mice protected from colitis by transfer of WT T reg cells 
(Fig. 2 D). Together, these results show that the inability of 
OX40/ T reg cells to inhibit colitis involves a complete 
deficiency in their control of innate and adaptive inflamma-
tory responses in the colon.
OX40 is required for early T reg cell accumulation  
in the lymphoid organs and colon during control  
of intestinal inflammation
Next, we assessed if OX40 expression by T reg cells was   
required for their accumulation in the lymphoid organs and 
CD4 Th cell responses and development of memory (Croft, 
2003), and targeting this pathway inhibits several autoim-
mune diseases (Sugamura et al., 2004). Increases in OX40+ 
and OX40L+ cells are associated with intestinal inflam-
mation in IBD patients and colitis in mice (Souza et al., 1999;   
Malmström et al., 2001). OX40 signaling plays a functional 
role in intestinal inflammation and blockade of OX40–
OX40L interactions inhibits colitis in various mouse models 
(Malmström et al., 2001; Takeda et al., 2004).
In contrast with conventional T cells, OX40 is expressed 
on the majority of CD4+Foxp3+ cells, even in the absence of 
activation (Fontenot et al., 2005; Vu et al., 2007). Despite 
these findings, little is known about the role of OX40 signal-
ing in T reg cell function. There are conflicting results from in 
vitro and in vivo studies, with evidence that OX40 signaling is 
either neutral or can promote or inhibit T reg cell–mediated 
suppression (Takeda et al., 2004; Valzasina et al., 2005; Golovina 
et al., 2008; Hippen et al., 2008; Piconese et al., 2008).
Here, we have examined the role of OX40 in influencing 
the balance between T eff and T reg cells in the intestine. 
Our results revealed a requirement for OX40 for the accu-
mulation of T reg cells in the normal colon. Importantly, 
OX40 expression by T reg cells was indispensable for sup-
pression of OX40-dependent colitogenic T cell responses.
RESULTS AND DISCUSSION
OX40 is preferentially expressed on intestinal T cells  
and promotes Foxp3+ T reg cell accumulation in the colon
Analysis of OX40 expression among CD4+ T cells in differ-
ent locations revealed compartmentalization of expression. In 
the lymphoid organs, OX40 was expressed primarily by 
CD4+Foxp3+ T cells with only a minority of CD4+Foxp3 
T cells showing positive staining (Fig. 1 A). Among colonic 
lamina propria leukocytes (cLPL), the percentage of OX40+ 
Foxp3+  cells  was  higher  than  in  lymphoid  organs  (84%;   
Fig. 1 A). OX40L mRNA expression was also increased in 
the colon compared with mesenteric LN (MLN) or spleen, 
probably reflecting the increased activation of APC in the   
intestine (Fig. 1 A).
Given the large proportion of T reg cells that expressed 
OX40 in systemic and mucosal compartments, we next ex-
amined the requirement for OX40 in T reg cell accumulation 
in vivo. There were no significant differences in the frequen-
cies or numbers of Foxp3+ T reg cells in the spleen (Fig. 1 B), 
as previously reported (Vu et al., 2007); there were also no 
differences in the MLN (Fig. 1 B) or in the BM (Fig. S1). In 
contrast, frequencies and absolute numbers of CD4+Foxp3+ 
T cells in the cLPL were 2.5- and 3.3-fold lower, respec-
tively, in OX40/ compared with WT mice (Fig. 1 B).
To determine whether the influence of OX40 on T reg 
cell accumulation in the intestine was cell intrinsic, we   
generated mixed BM chimeras using WT (CD45.1) and 
OX40/ (CD45.2) BM cells (Fig. 1 C). 8 wk after BM   
reconstitution, TCR+Foxp3+ T reg cells derived equally 
from WT or OX40/ BM in the MLN, and there was only 
a small increase in the proportion of Foxp3+ cells derived JEM VOL. 207, April 12, 2010  701
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Figure 1.  OX40 is preferentially expressed on intestinal T cells and promotes Foxp3+ T reg cell accumulation in the colon in a cell intrinsic 
way. (A, left) Tissues from WT mice analyzed by flow cytometry for CD4, Foxp3, and OX40 expression. Percentages of OX40+ cells among CD4+ Foxp3  
or Foxp3+ cells are indicated in representative dot plots (n = 5). (right) OX40L mRNA amounts in spleen, MLN, and total colon homogenate (n = 5). Values 
are normalized to CD45 and are mean values (± SEM) relative to spleen (set to 1). (B) Percentages and total numbers of Foxp3 and Foxp3+ CD4 T cells in 
tissues of WT and OX40/ mice. (C) BM cells from WT congenic mice (CD45.1+) mixed in equal proportion with BM cells from OX40/ mice (CD45.2+) 
were injected i.v. into irradiated RAG/ mice. 8 wk after transfer, tissues were harvested and stained for TCR-, CD45.2, and Foxp3. Representative  
staining (top) and the ratio of WT/OX40/ progeny among TCR+ cells are shown (bottom). Each point represents an individual mouse and horizontal 
bars represent group means (B and C). Data are representative of two to three independents experiments.702 OX40 and T reg–mediated control of colitis | Griseri et al.
colon at a similar frequency in mice cotransferred with 
OX40/ or WT T reg cells. Indeed, in the colon the total 
number of OX40/ Foxp3+ T reg cells was fourfold in-
creased compared with the number of WT Foxp3+ T reg 
cells (Fig. 3 C).
These results suggest that T reg cells that do not express 
OX40 fail to compete effectively with colitogenic T cells up 
to a month after cotransfer, resulting in the development of 
colitis. After disease onset, the requirement for OX40 signal-
ing for T reg cell accumulation in the intestine is reduced, 
but the T reg cells that accumulate under these circumstances 
fail to suppress the disease.
OX40/ T reg cells show normal proliferative responses  
and retain Foxp3 expression after transfer
As OX40/ T reg cells were impaired in their accumula-
tion during the first month after cotransfer, we investigated 
whether their proliferative capacity was reduced. OX40/ 
and WT CD45.2+Foxp3+ T reg cells showed a similar prolif-
erative response as assessed by Ki67 staining 2 wk after   
cotransfer in MLN and cLPL (Fig. 4 A). This may suggest 
that the reduction of OX40/ T reg cells is a consequence 
of impaired survival signals rather than proliferation defects. 
colon in T cell transfer colitis. To distinguish Foxp3+ cells 
derived  from  T  reg  progeny  from  those  derived  from 
CD4+CD45RBhi precursors, we isolated colitogenic and   
regulatory populations from CD45.1+ and CD45.2+ mice,   
respectively (Fig. 3 A).
2 wk after transfer, before disease onset, there was an ap-
proximately twofold reduction in the total number and fre-
quency of CD45.2+ CD4+ Foxp3+ cells in the spleen and MLN 
of mice cotransferred with OX40/ T reg cells compared 
with mice cotransferred with WT T reg cells (Fig. 3 B). In the 
colon, differences were even more marked, as OX40/ T reg 
cells were fourfold less frequent and 3.5-fold reduced in total 
number compared with similarly transferred WT T reg cells 
(Fig. 3 B). Thus, although OX40 strongly influences T reg 
accumulation in the colon, it may also promote T reg cell ac-
cumulation during inflammation at any site in which T reg 
cells have to compete with a proliferative T eff cell population. 
Importantly, 1 mo after transfer, CD45.2+Foxp3+ frequen-
cies among CD4+ T cells were still 2-fold lower in lymphoid 
organs and 2.5-fold lower in the colon of mice transferred 
with OX40/ compared with WT T reg cells (Fig. S2).
8 wk after transfer, the picture was very different, with 
CD45.2+CD4+Foxp3+ T cells present in spleen, MLN, and 
Figure 2.  OX40 expression on T reg cells is required to suppress T cell induced colitis. RAG/ mice received WT CD4+CD45RBhi T cells alone  
(no TR), or in combination with WT or OX40/ CD4+CD25+ T reg cells (TR). (A) Mean weight of six animals per group (± SEM). (B) Colitis score at 8 wk.  
An additional control group showed that OX40/ T reg cells do not induce colitis by themselves. (C) Photomicrographs of mid-colon sections. Bar, 100 µm. 
(D) Number of colonic IFN-+ and IL-17+CD4+ T cells, neutrophils (CD11cCD11bhiGr1hiSSChi) and monocytes/macrophages (CD11cCD11bhiGr1intSSClo)  
at 8 wk. Each point represents an individual mouse and horizontal bars represent group means (B and D). Results are representative of three  
independent experiments.JEM VOL. 207, April 12, 2010  703
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OX40/ and WT CD45.2+ T reg cells (unpublished data). 
However, OX40/ T reg cells exhibited a less activated/
memory phenotype (CD44+CD62L) than WT T reg cells   
8 wk after transfer in the colon (Fig. 4 B) and MLN (unpub-
lished data). OX40 promotes the acquisition of an effector/
memory phenotype by activated CD4 T cells (Watts, 2005) 
and may therefore favor the full activation of T reg cells 
during control of inflammatory responses. In addition, the 
frequency of glucocorticoid-induced TNF receptor (GITR)hi 
T reg cells was significantly higher in OX40/ compared 
with WT Foxp3+ T reg cells in both the late and early phase 
of the disease, as well as in lymphocyte-replete mice at steady-
state (Fig. 4 C). This raises the possibility that increased 
GITR signaling in OX40/ T reg cells may affect their 
suppressive function (Shimizu et al., 2002). GITR may also 
promote the late accumulation of OX40/ T reg cells in 
the colon, as a GITR signal can support the in vivo expan-
sion of Foxp3+ T reg cells (Shevach and Stephens, 2006; 
Furthermore,  the  expression  of  the  47  integrin  in  the 
MLN was also similar, indicating that OX40/ T reg cells 
are not impaired in the up-regulation of colon-homing   
receptors after activation (Fig. 4 A).
Despite the late accumulation of T reg cells in the colon 
of mice cotransferred with OX40/ T reg cells, there   
was  no  suppression  of  disease.  Decreased  expression  of 
Foxp3 or CD25 by T reg cells can lead to their loss of sup-
pressor  functions,  production  of  inflammatory  cytokines, 
and autoimmune disease (Wan and Flavell, 2007; Tang   
et al., 2008). This did not seem to be the case as Foxp3 
(MFI and percentage of Foxp3+ cells among T reg cell 
progeny)  and  CD25  expression  were  similar  between 
OX40/ and WT CD45.2+ T reg cells present at 8 wk in 
the colon, and these cells did not express inflammatory cyto-
kines IL-17 or IFN- (Fig. 4 B).
Analysis of other molecules linked to T reg function 
such as CTLA-4 or IL-10 showed no differences between 
Figure 3.  OX40 is required for early Foxp3+ T reg cell accumulation in the lymphoid organs and colon during control of intestinal inflam-
mation. (A) CD45.1+ CD4+CD45RBhi T cells were cotransferred with CD45.2+ WT or OX40/ T reg cells (TR) into RAG/ mice. Numbers and percentages of 
CD45.2+CD4+Foxp3+ cells in tissues 2 wk (B) and 8 wk (C) after cotransfer. Each point represents an individual mouse. Data are representative of three 
independent experiments.704 OX40 and T reg–mediated control of colitis | Griseri et al.
in the absence of an OX40 signal, and this was accompanied 
by a twofold increase in the percentage of apoptotic cells 
(Annexin V+) at day 5 (Fig. 5 B). Importantly, OX40/ T reg 
cells were also more sensitive to apoptosis than WT T reg 
cells 2 wk after cotransfer with CD4+CD45RBhigh cells as 
shown by Annexin V staining on colonic Foxp3+ cells after 
overnight culture (Fig. 5 C). Together, these results show 
that OX40 promotes the accumulation of TCR-activated 
T reg cells by rendering them less sensitive to activation-
induced cell death.
OX40 expression on T cells is required for  
development of colitis
Despite reductions in Foxp3+ T reg cells in the intestine of 
OX40-deficient mice, there was no sign of colitis in these 
mice (unpublished data). To test whether OX40 signaling 
van Olffen et al., 2009). Further experiments are required 
to establish any functional role of GITR in this model.
Lack of OX40 signaling renders activated T reg cells more 
susceptible to apoptosis
Next, we assessed whether OX40 deficiency in T reg cells 
was associated with impaired survival after activation. FACS-
sorted CD25+ T reg cells were activated with anti-CD3 in 
the presence of APC and exogenous IL-2. Anti-OX40L–
blocking mAb or OX40/ T reg cells were used to test the 
influence of OX40 on T reg cell survival after activation. In 
line with in vivo results, Foxp3+ T reg cell proliferation in vitro 
as assessed by CFSE dilution and Ki67 expression (Fig. 5 A) 
was unaffected by the absence of an OX40 signal. Despite this, 
there was an approximately twofold reduction in the total 
number of Foxp3+ T reg cells that accumulated after activation 
Figure 4.  Phenotypic and functional characteristics of WT and OX40/ T reg cells after transfer. CD45.1+ CD4+CD45RBhi T cells were  
transferred with CD45.2+ WT or OX40/ T reg cells (TR) into RAG/ mice. (A) Ki67 expression in cLPL and MLN and 47 integrin expression in MLN on 
Foxp3+ T reg progeny at wk 2. (B) Foxp3, CD25, CD44, CD62L expression, IL-17, and IFN- secretion by Foxp3+ T reg progeny at wk 8 in cLPL. (C) GITR  
expression by Foxp3+ T reg progeny at 2 wk (dot plots) and 8 wk (graph) and CD4+ T cells from the spleen of normal mice (dot plots). Percentages of GITRhi 
cells among CD4+Foxp3+ cells and GITR MFI on Foxp3+GITR+cells are indicated in dot plots. Data are representative of two independent experiments.JEM VOL. 207, April 12, 2010  705
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These results show that OX40 expression by T cells pro-
motes colitogenic Th1 responses, which are known to drive 
colitis in this model (Powrie et al., 1994). The results are 
also consistent with our earlier findings that anti-OX40L 
mAb inhibited T cell transfer colitis (Malmström et al., 
2001). The requirement for OX40 signaling to sustain coli-
togenic  T  cell  responses  explains  the  lack  of  colitis  in 
OX40/ mice. In addition, an inability of OX40/ T reg 
cells to compete for the inflammatory resource OX40L in 
the gut may well contribute to their inability to control 
OX40+ effector responses in the gut.
Here, we describe an essential role for OX40 in Foxp3+ 
T reg cell homeostasis and control of intestinal inflamma-
tion. OX40 deficiency abolished the ability of T reg cells 
in T cells is also required for colitogenic T cell responses, 
we transferred OX40/ and WT CD4+CD45RBhi T cells 
to RAG/ mice. Although the latter induced wasting dis-
ease and colitis, OX40/ CD45RBhi T cells failed to in-
duce  wasting  disease  and  led  to  marked  amelioration  of 
colitis (Fig. 6 A). Consistent with a requirement for OX40 
signaling  for  a  sustained  inflammatory  response,  OX40L 
mRNA  expression  was  increased  in  the  inflamed  colon 
(Fig.  6  B).  Reduced  colitis  after  transfer  of  OX40/ 
CD45RBhi  T  cells  was  associated  with  fourfold  fewer 
CD4+IFN+ T cells in the colon (Fig. 6 C). Similar reduc-
tions in colonic CD4+TNF+ T cells (unpublished data) were 
also observed in line with the previously described influ-
ence of OX40 on TNF-secreting T cells (Ito et al., 2005). 
Figure 5.  Lack of an OX40 signal renders activated T reg cells more susceptible to apoptosis. WT or OX40/ CD25+ FACS sorted T reg cells  
were cultured in triplicate for 5 d with irradiated APC and soluble anti-CD3, in the presence of an anti-OX40L mAb or isotype control. hIL-2 was added to 
the cultures (200U/ml). (A) Representative dot plots of CFSE dilution by CD4+Foxp3+ cells. Bar graphs represent means of Ki67 expression by Foxp3+ cells 
and total number of CD4+Foxp3+ cells at d 5 (mean of triplicate cultures ± SD). (B) Representative Annexin V-7 ADD staining 5 d after T reg cell activation 
(gated on CD4+ T cells). Bar graph represents mean percentages of apoptotic cells (mean of triplicate cultures ± SD). **, P < 0.001. Results are  
representatives of two to three independent experiments. (C) CD4+CD45RBhi T cells were transferred into RAG/ mice with CD25+ TR cells isolated from 
WT or OX40/ Foxp3-GFP mice. Numbers in dot plots represent the percentages of Annexin V+ cells at 2 wk among colonic CD4+Foxp3(GFP)+ cells, after  
overnight culture in medium. Three to four colons were pooled per group, and results are representative of two independent experiments.706 OX40 and T reg–mediated control of colitis | Griseri et al.
colitis (unpublished data), TLR2, and IL-2 (Chen et al., 
2009; van Olffen et al., 2009).
The accumulation of Foxp3+ T reg cells in both the lym-
phoid organs and intestine was highly dependent on OX40 
expression upon transfer into lymphopenic mice, whereas 
under homeostatic conditions, OX40 was not essential for 
accumulation in lymphoid organs. The majority of T reg 
cells undergo proliferation upon transfer to RAG/ mice 
(80%; Fig. 4 A) and this increased pressure, particularly in 
an environment where IL-2 may be limiting, could explain 
the more general requirement for OX40 signaling under 
these conditions. The inability of OX40/ T reg cells to 
keep up with OX40-competent colitogenic T cells in the 
earlier phase of the response could directly account for their 
inability to control colitis. Indeed, CCR4/ CD25+ T reg 
cells were unable to prevent T cell–induced colitis as a conse-
quence of reduced accumulation in the MLN early in the   
to suppress T cell transfer colitis. This was associated with an 
early impairment in the accumulation of Foxp3+ T reg cells 
in the colon and lymphoid organs. OX40 signaling protected 
activated T reg cells from apoptosis and promoted their sur-
vival in vitro and when analyzed directly ex vivo. An in-
creased sensitivity to activation-induced cell death provides 
an explanation of why OX40/ T reg cells are less able to 
accumulate after transfer and compete with OX40-dependent 
colitogenic T cell responses. Indeed, an antiapoptotic effect 
of OX40 was previously described in CD4+ T eff cells, pro-
moting their long-term survival (Song et al., 2005). Interest-
ingly,  inflammation  overrides  the  requirement  for  OX40 
signaling, as late accumulation of OX40/ T reg cells was 
not impaired in colitic mice. Several inflammatory molecules 
are able to support the survival of T reg cells and may pro-
mote the late accumulation of OX40/ T reg cells during 
colitis. These include GITRL, which was increased during 
Figure 6.  OX40 is required for the development of colitogenic T cell responses. RAG/ mice received CD4+CD45RBhi T cells from WT or OX40/ 
donors. (A) Mean weight loss (n = 6 ± SEM) and colitis score at wk 8. Representative photomicrographs of mid-colon sections are shown below. Bar,  
100 µm. (B) Amount of OX40L mRNA in total colon homogenate from untransferred mice (RAG/) or colitic mice (RBhi) at wk 8. Data shown are the mean 
values (n = 4) relative to untransferred RAG/ mice (set to 1), after normalization to HPRT expression. (C) Number of colonic IFN-+ and IL-17+ CD4+  
T cells 8 wk after transfer. Each point in (A, right) and (C) represents an individual mouse. Results are representative of three independent experiments.JEM VOL. 207, April 12, 2010  707
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injected i.p. where indicated. Mice were monitored weekly for wasting dis-
ease, and any mice losing >20% of its starting body weight or showing 
severe signs of disease were killed.
Histological assessment of intestinal inflammation. Mice were killed 
7–8 wk after T cell reconstitution, and samples of proximal colon, mid-colon, 
and distal colon were fixed in buffered 10% formalin solution. 5-µm paraffin-
embedded sections were cut and stained with hematoxylin and eosin and in-
flammation was scored in a blinded fashion using a previously described 
scoring system (Izcue et al., 2008).
Generation of BM chimeras. BM was isolated from congenic B6.SJL-
Cd45 mice and C57BL/6 OX40/ age-matched mice and mixed at a 
1:1 ratio. -Irradiated (5.5 Gy, 550 rad) C57BL/6 RAG/ recipients were   
injected with 5.106 mixed BM cells/mouse i.v.
Isolation  of  leukocyte  subpopulations  and  FACS. Cell suspensions 
were prepared from spleen, MLN, BM, and cLPL as previously described 
(Izcue et al., 2009). Lymphocytes from lung and liver were isolated as previ-
ously described (Sather et al., 2007). The following antibodies were used for 
flow cytometry: anti-Gr1 and -CD45.2 conjugated to FITC, anti-CD4 con-
jugated to PerCP or FITC, anti–TCR-, anti-47, anti-CD11c, and anti-
CD62L conjugated to PE, anti-CD11b conjugated to APC, biotinylated 
anti-CD45.2, anti-OX40, anti-GITR, anti-CD44 (all from BD), or appro-
priate isotype controls. Biotinylated antibodies were detected with PerCP or 
FITC-conjugated streptavidin (BD). Intracellular cytokines staining after 4 h 
PMA and ionomycin restimulation and Foxp3 staining were performed as 
previously described (Izcue et al., 2008). Apoptosis sensitivity was measured 
by Annexin V staining (BD) of CD4 T cell enriched samples after 15 h   
of culture in medium without restimulation or cytokines, as previously   
described (Ruby et al., 2008).
T reg cell cultures. CD4+CD25+ T reg cells (5 × 104/well) were FACS 
sorted from the spleen of WT or OX40/ mice (95% Foxp3+) and labeled 
with CFSE where indicated. T reg cells were stimulated with irradiated APC 
(105/well; T cell free splenocytes), soluble anti-CD3 (145-2c11; 1 µg/ml), 
recombinant hIL-2 (PeproTech, 200 U/ml) and either blocking anti-OX40L 
antibody (OX89; 10 µg/ml) or IgG1 isotype control. Cells were cultured in 
96-well round-bottom plates for 5 d in complete RPMI (Invitrogen) containing 
5% FCS, 2 mM l-glutamine, 0.05 mM 2-mercaptoethanol, and 100 U/ml 
each of penicillin and streptomycin. Live cells at d 5 were counted using try-
pan blue. Proliferation of CD4+Foxp3+ was assessed by CFSE dilution and 
Ki67 staining; apoptosis was assessed using Annexin V and 7-AAD staining.
Quantitation of gene expression using real-time PCR. Total RNA 
was purified from frozen tissue samples using RNAeasy kits (QIAGEN). 
Homogenization was performed using a Fastprep 24 Homogenizer (MP   
Biomedicals). cDNA synthesis was performed using Superscript III reverse 
transcription and Oligo dT primers (both from Invitrogen). Quantitative PCR 
reactions were performed using SYBR green PCR SensiMix (Quantace) 
and the following reagents: OX40L primers, 5-GTTCTGCACCTC-
CATAGTTTGA-3 and 5-GGATGCTTCTGTGCTTCATCT-3. cDNA 
samples were assayed in triplicate using a Chromo4 detection system (MJ 
Research), and gene expression levels for each individual sample were nor-
malized to HPRT (QuantiTect; QIAGEN). Mean relative gene expres-
sion was determined, and the differences were calculated using the 2∆C(t) 
method (Pfaffl, 2001).
Statistical analysis. Statistical analysis was performed with Prism 5.0 
(GraphPad Software). The nonparametric Mann-Whitney test was used 
for all statistical comparisons, except for the T reg cell cultures where an 
unpaired Student’s t test was used. Differences were considered statistically   
significant when P < 0.05.
Online supplemental material. Fig. S1 shows that the frequency of Foxp3+ 
T reg cells was decreased in the lung and liver of OX40/ mice compared 
response (Yuan et al., 2007). Furthermore, recent studies have 
highlighted the importance of the T reg cell/T eff cell ratio 
for efficient control of colitis (Darrasse-Jèze et al., 2009).
T reg cells can suppress T eff cell responses by modulating 
APC (Cederbom et al., 2000) and by out-competing conven-
tional T cells for interactions with APC (Onishi et al., 2008). 
Because the majority of T reg cells express OX40, they may 
be particularly poised to interact with OX40L+ DCs, which 
are abundant in the MLN of colitic mice (Malmström et al., 
2001). In contrast, OX40/ T reg cells may be impaired in 
their ability to compete with activated OX40+ T eff cells for 
interactions with OX40L+ DC, resulting in sustained OX40 
signaling  into  T  eff  cells,  which  promotes  colitis.  Recent 
studies have shown that to suppress particular Th responses,   
T reg cells need to express signature transcription factors that 
drive distinct T eff cell responses. Thus, to inhibit Th1, Th2, 
or Th17 responses, T reg cells need to express T-bet (Koch   
et al., 2009), IRF-4 (Zheng et al., 2009), and Stat3 (Chaudhry 
et al., 2009), respectively. These results emphasize the func-
tional specialization of T reg responses and indicate that to 
compete effectively with distinct types of effector responses, 
T reg cells need to be able to compete in a particular niche. 
Our data suggest that along these lines, OX40 expression on 
T reg cells may be required to effectively compete with OX40-
dependent colitogenic T cell responses.
Further understanding of the factors that influence the 
balance between effector and T reg cells in the gut is required 
for the rational design of therapies that inhibit intestinal   
inflammation while promoting T reg cell activity.
MATERIALS AND METHODS
Mice. Wild-type C57BL/6, congenic B6.SJL-Cd45, C57BL/6 RAG/, 
C57BL/6 OX40/ mice, and Foxp3-GFP knock-in mice were bred and 
maintained under specific pathogen–free conditions in accredited animal   
facilities at the Sir William Dunn School of Pathology (University of   
Oxford, Oxford, England, UK). OX40/ mice (Pippig et al., 1999) were 
crossed nine times on the C57BL/6 background. OX40/ Foxp3-GFP 
mice were generated by crossing OX40/ mice with C57BL/6 Foxp3-
GFP knock-in mice (Fontenot et al., 2005). All procedures involving   
animals  were  conducted  according  to  the  requirements  and  with  the   
approval of the UK Home Office Animals (Scientific Procedures) Acts, 
1986. Mice were negative for Helicobacter spp. and other known intestinal 
pathogens and were 6–10 wk old when first used.
Purification of CD4+ T cell subsets. CD4+ T cells were purified from 
spleens by negative depletion using rat anti–mouse CD8 (clone YTS 169), 
B220 (RA3-6B2), MHC class II (TIB 120), and Mac-1 (M1-70) together 
with anti–rat coated Dynabeads (Invitrogen). Enriched CD4+ single-cell   
suspensions were stained with anti-CD4, anti-CD25, and anti-CD45RB (all 
obtained from BD). Naive CD4+CD25CD45RBhi T cells and regulatory 
CD4+CD25+CD45RBlo T cells were purified (>99%) on a cell sorter   
(MoFlo; Dako). Subsequent FACS analysis showed that at least 95% of 
CD4+CD25+CD45RBlo  cells  were  Foxp3+  and  99%  of  CD4+CD25 
CD45RBhi cells were Foxp3 (Izcue et al., 2008).
T cell transfer model of colitis. Naive CD4+CD25CD45RBhi T cells 
were  isolated  from  congenic  B6.SJL-Cd45  (CD45.1+)  mice,  WT  or 
OX40/ C57BL/6 mice and injected i.p. into 6–10-wk-old C57BL/6 
RAG/ immunodeficient recipients (4 × 105 cells/mouse). WT and 
OX40/ CD4+CD45RBloCD25+ T reg cells (2 × 105/mouse) were co- 708 OX40 and T reg–mediated control of colitis | Griseri et al.
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